The Prox1–Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors

  1. Guillermo Oliver1
  1. 1Department of Genetics,
  2. 2Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA;
  3. 3Wihuri Research Institute,
  4. 4Translational Cancer Biology Program, University of Helsinki, Helsinki 00014, Finland
  1. Corresponding author: guillermo.oliver{at}stjude.org
  1. 7 These authors contributed equally to this work.

  • Present addresses: 5Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104 USA;

  • 6 Division of Animal Sciences, Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.

Abstract

The mammalian lymphatic vasculature is important for returning fluids from the extracellular tissue milieu back to the blood circulation. We showed previously that Prox1 dosage is important for the development of the mammalian lymphatic vasculature. The lack of Prox1 activity results in the complete absence of lymphatic endothelial cells (LECs). In Prox1 heterozygous embryos, the number of LECs is reduced because of a decrease in the progenitor pool in the cardinal vein. This reduction is caused by some progenitor cells being unable to maintain Prox1 expression. In this study, we identified Vegfr3, the cognate receptor of the lymphangiogenic growth factor Vegfc, as a dosage-dependent, direct in vivo target of Prox1. Using various mouse models, we also determined that Vegfr3 regulates Prox1 by establishing a feedback loop necessary to maintain the identity of LEC progenitors and that Vegfc-mediated activation of Vegfr3 signaling is necessary to maintain Prox1 expression in LEC progenitors. We propose that this feedback loop is the main sensing mechanism controlling the number of LEC progenitors and, as a consequence, the number of budding LECs that will form the embryonic lymphatic vasculature.

Keywords

Footnotes

  • Received February 18, 2013.
  • Accepted August 21, 2014.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance